RE:A Q on The A Forum
I'd be interested to know why xB3-001 is so expensive to manufacture, as in I thought the whole point of the 2010/2011ish 12-amino acid Transcend (now xB3) was that it binned the complexity of "parent" melanotransferrin p97, and thus made it much much easier to make the conjugates.
And come to that, anyone know how much it cost to make the first Herceptin conjugate (BT2111?) as used in 2011ish Texas Tech pre-clinical trials? Or was that manufacturing process using different production standards?
And how much do the other conjugates cost? Both for clinical and pre-clinical if it makes a difference?
MD